renal dysfunction

Related by string. Renal dysfunction * Rend al . Rend Al . Renal . Renald . RENAL : chronic renal failure . acute renal failure . End Stage Renal . impaired renal / dysfunctions . Dysfunction . dysfunctioning . Dysfunctions : treat erectile dysfunction . erectile dysfunction impotence . erectile dysfunction ED . erectile dysfunction medication * renal dysfunction acute renal *

Related by context. All words. (Click for frequent words.) 75 renal insufficiency 73 left ventricular dysfunction 71 hyperkalemia 70 thromboembolic events 70 β blockers 69 severe renal impairment 69 renal impairment 69 hypercalcemia 69 upper gastrointestinal bleeding 69 nephrotoxicity 68 EXJADE 68 severe renal insufficiency 68 cytopenias 68 beta blocker therapy 68 severe neutropenia 68 myopathy rhabdomyolysis 68 microalbuminuria 68 endometrial hyperplasia 68 hypomagnesemia 68 subclinical hypothyroidism 68 Erythropoietic therapies may 68 hepatotoxicity 68 ATACAND 68 TNF antagonist 67 tumor lysis syndrome 67 albuminuria 67 thrombotic events 67 overt nephropathy 67 metabolic acidosis 67 revascularization procedures 67 serum creatinine levels 67 proteinuria 67 adrenal insufficiency 67 atrioventricular block 67 myocardial ischemia 67 systemic corticosteroid 67 concomitant medications 67 aminotransferases 67 immunosuppressive agents 67 extrapyramidal symptoms 67 hepatic failure 67 reinfarction 66 thromboembolism 66 intravenous bisphosphonates 66 carotid stenosis 66 cerebrovascular events 66 thyrotoxicosis 66 unstable angina pectoris 66 hypokalemia 66 thromboembolic complications 66 steatosis 66 APTIVUS r 66 systolic dysfunction 66 systemic corticosteroids 66 lactic acidosis 66 CVD mortality 66 salmeterol HFA MDI 66 nonfatal MI 66 kidney dysfunction 66 VIIBRYD 66 torsade de pointes 66 QTc interval 66 torsades de pointes 66 renal function 66 macrovascular events 66 hematologic toxicity 66 adrenal suppression 66 oral antidiabetic medication 66 cardiac dysfunction 66 hypocalcemia 66 macroalbuminuria 66 hallucinations dyskinesia 66 elevated triglyceride levels 66 rFVIIa 66 thromboembolic 65 hepatic impairment 65 myocardial infarction stroke 65 microvascular disease 65 electrolyte abnormalities 65 recurrent ischemia 65 intracranial hemorrhage ICH 65 nephropathy 65 mild renal insufficiency 65 colorectal adenoma 65 QT prolongation 65 creatinine clearance 65 macrovascular disease 65 left ventricular hypertrophy 65 hepatorenal syndrome 65 corticosteroid therapy 65 TEAEs 65 cerebrovascular accident 65 BYSTOLIC 65 dysfunction LVSD 65 postoperative morbidity 65 arterial thromboembolic events 65 cardiogenic shock 65 decompensated heart failure 65 thrombotic complications 65 LV dysfunction 65 impaired renal 65 elevated ALT 65 proliferative diabetic retinopathy 65 β blocker 65 NATRECOR ® 65 hyperphenylalaninemia HPA due 65 primary aldosteronism 65 cerebral infarction 65 proliferative retinopathy 65 neurologic symptoms 65 QTc prolongation 65 paricalcitol 65 hyperglycaemia 65 levodopa therapy 64 periprocedural 64 antiarrhythmic drug 64 orthostatic hypotension 64 hyperalgesia 64 fluid overload 64 hemorrhagic complications 64 SHPT 64 loop diuretics 64 hypercalcaemia 64 aldosterone antagonist 64 recurrent VTE 64 SGPT 64 moderate renal impairment 64 biliary tract disease 64 advanced adenoma 64 glycated hemoglobin levels 64 comorbid conditions 64 bone marrow suppression 64 PREZISTA r 64 hypophosphatemia 64 renal scarring 64 postoperative pulmonary 64 severe hypersensitivity reactions 64 serum phosphate 64 GnRH agonists 64 endotoxemia 64 paroxysmal AF 64 tamsulosin 64 thrombolytic agents 64 symptomatic VTE 64 microvascular complications 64 thrombocytosis 64 elevated serum creatinine 64 pheochromocytoma 64 postoperative complication 64 severe exacerbations 64 thrombolytic therapy 64 nephrotoxic drugs 64 LVSD 64 POAG 64 salmeterol fluticasone 64 postoperative mortality 64 hyperglycemia 64 hypotension 64 acute renal failure 64 renal toxicity 64 ventricular dysfunction 64 receiving VELCADE 64 methemoglobinemia 64 perioperative mortality 64 leukemia AML 64 nonalcoholic steatohepatitis 64 thrombocytopenic 64 induce orthostatic hypotension 64 transaminase elevations 64 non squamous NSCLC 64 NYHA Class II 64 asymptomatic carotid stenosis 64 hyperparathyroidism 64 TMP SMX 64 ribavirin therapy 64 nesiritide 64 platelet reactivity 64 myocardial infarctions 64 nondiabetic patients 64 hypertensives 64 hypoxemia 64 postoperative atrial fibrillation 64 cardiovascular mortality 64 syncope 64 cardiac toxicity 64 autonomic dysfunction 63 hypersensitivity reaction 63 neurologic complications 63 serum creatinine 63 warfarin therapy 63 ipsilateral stroke 63 coronary revascularization 63 renal artery stenosis 63 sinus bradycardia 63 infarctions 63 recurrent DVT 63 left ventricular systolic 63 androgen deprivation 63 Hypotension 63 aldosterone antagonists 63 inotropic 63 subtrochanteric 63 angiotensin converting enzyme inhibitor 63 antihypertensive therapy 63 COPD exacerbation 63 prolonged QT interval 63 secondary hyperparathyroidism 63 ACTOplus met XR 63 lichen planus 63 neutropenia dehydration dyspnea 63 adenomatous polyps 63 lipid abnormalities 63 aortic regurgitation 63 NPH insulin 63 Torsades de Pointes 63 glomerular filtration rate 63 myelosuppression 63 bacteriuria 63 tolvaptan 63 neutropenic patients 63 amenorrhoea 63 polyp recurrence 63 bronchospasm 63 macrovascular complications 63 severe hypoglycemia 63 calcineurin inhibitors 63 systolic hypertension 63 ABCB1 63 definite stent thrombosis 63 lipid lowering therapies 63 paclitaxel eluting stents 63 K ras mutations 63 nonischemic 63 CMV infection 63 hyperphosphatemia 63 T2DM 63 silent ischemia 63 serum urate levels 63 comorbidities 63 cTnT 63 QTc 63 morphometric vertebral fractures 63 choroidal neovascularization 63 fibrinolysis 63 Thrombocytopenia 63 hypovolemia 63 CMV disease 63 PAOD 63 atherogenic dyslipidemia 63 fatal myocardial infarction 63 varices 63 elevated IOP 63 postoperative AF 63 alanine aminotransferase 63 pancytopenia 63 ejection fractions 63 coagulopathy 63 unfavorable cytogenetics 63 NATRECOR R 63 FASLODEX 63 pericardial effusions 62 alanine aminotransferase ALT 62 elevated LDH 62 ACTOplus met 62 chronic metabolic acidosis 62 neurologic deficits 62 antihypertensive medications 62 thyrotropin levels 62 ischemic cardiomyopathy 62 myocardial infarction MI 62 stable angina 62 hepatic dysfunction 62 pulmonary exacerbations 62 serum sodium 62 serum potassium 62 glycoprotein IIb IIIa inhibitors 62 myocardial infarction 62 MGUS 62 strong CYP#A# inducers 62 antibiotic prophylaxis 62 haemorrhagic stroke 62 Endothelial dysfunction 62 sulfasalazine 62 antiplatelet drugs 62 contrast induced nephropathy 62 VAPRISOL 62 reoperations 62 primidone 62 pentoxifylline 62 tiotropium 62 prednisone prednisolone 62 cranial irradiation 62 MACCE 62 ventricular fibrillation VF 62 clinically detectable 62 CK MB 62 CTEPH 62 Proteinuria 62 concomitant medication 62 co morbidities 62 antiplatelet medications 62 PSADT 62 hepatocellular 62 mycophenolate mofetil 62 benazepril 62 Hyperlipidemia 62 CrCl 62 certolizumab 62 mixed hyperlipidemia 62 perioperative complications 62 noncardiac 62 aspartate aminotransferase AST 62 HMG CoA reductase inhibitors 62 diastolic heart 62 GnRH agonist 62 antiarrhythmic drugs 62 preserved ejection fraction 62 metabolic alkalosis 62 CYP #A# 62 adrenalectomy 62 bypass grafting 62 leukopenia 62 mL/min/#.# m 2 62 atrophic gastritis 62 rebleeding 62 hemodynamic instability 62 virologic failure 62 ALT flares 62 progressive dyspnea 62 uncontrolled hypertension 62 mycophenolic acid 62 anaphylactoid reactions 62 deep venous thromboses 62 serum calcium levels 62 posttransplant 62 pericardial effusion 62 HIV HCV coinfected 62 parkinsonism 62 Microalbuminuria 62 glycosylated hemoglobin HbA1c 62 cytotoxic chemotherapy 62 liver dysfunction 62 PSA nadir 62 prostate TURP 62 HbA1c levels 62 asthma exacerbation 62 hypercholesterolaemia 62 PNH patients 62 post thrombotic syndrome 62 node metastases 62 weekly subcutaneous injections 62 HF hospitalization 62 COREG 62 advanced adenomas 62 androgen suppression 62 Infusion Reactions Severe 62 serum phosphorous 62 nephrotoxic 62 cardiovascular disease hypertension 62 HBeAg negative 62 recurrent glioblastoma multiforme 62 hypoglycemic events 62 interferon alfa 2a 62 angiotensin converting enzyme inhibitors 62 pulmonary infiltrates 62 mycophenolate 62 coagulation abnormalities 62 locoregional recurrence 62 systemic hypotension 62 hypervolemic hyponatremia 62 BENICAR HCT 62 lung edema 62 onset diabetes mellitus 62 hyperbilirubinemia 62 adenoma 62 Renal dysfunction 62 MULTAQ 62 Eisenmenger syndrome 62 intravenous diuretics 62 hyperammonemia 62 dopaminergic therapy 62 subclinical hyperthyroidism 62 occlusive disease 62 neutropaenia 61 hypokalemia hypomagnesemia 61 heparin induced thrombocytopenia 61 AST ALT 61 cardioembolic stroke 61 variceal hemorrhage 61 systemic embolism 61 IIIa inhibitor 61 fluvastatin 61 rhythm disturbances 61 vertebral fracture 61 HSCT 61 transaminase levels 61 angina pectoris 61 aspartate aminotransferase 61 Lactic acidosis 61 pulmonary dysfunction 61 intravesical therapy 61 phosphate binders 61 artery stenosis 61 D dimer 61 lipid lowering agents 61 xanthine oxidase inhibitor 61 severe hypoglycemic 61 vasovagal syncope 61 transaminases 61 nicardipine 61 cardiac troponin 61 postoperative chemotherapy 61 COPD exacerbations 61 AGILECT R 61 euvolemic 61 ertapenem 61 thromboembolic disease 61 troponin T 61 nonhematologic adverse reactions 61 inotropes 61 bezafibrate 61 serum triglyceride levels 61 gastrointestinal perforation 61 Pulmonary hypertension 61 delayed CINV 61 systemic toxicity 61 immunosuppressant therapy 61 intracerebral haemorrhage 61 transurethral resection 61 efalizumab 61 Hashimoto thyroiditis 61 nonmelanoma skin cancers 61 OADs 61 distant metastasis 61 achieved ACR# 61 acute myocardial infarction AMI 61 venous thrombosis 61 ventricular arrhythmias 61 serum aminotransferase levels 61 syncope fainting 61 skeletal metastases 61 esophagitis 61 postoperative complications 61 glomerular filtration 61 acute decompensation 61 potassium sparing diuretics 61 serum PSA 61 cardiovascular hospitalizations 61 rosuvastatin #mg 61 fibrosis scarring 61 probiotic supplementation 61 acute phosphate nephropathy 61 valvular disease 61 cholecystitis 61 % AST SGOT 61 Zollinger Ellison syndrome 61 recurrent wheezing 61 dobutamine 61 methimazole 61 tirofiban 61 cardiovascular hospitalization 61 FluCAM arm 61 ventricular tachyarrhythmia 61 corticosteroids 61 metastatic malignant 61 candesartan 61 colorectal liver metastases 61 acute hepatic 61 diastolic dysfunction 61 ursodeoxycholic acid 61 ventricular arrhythmia 61 choroidal neovascularization CNV 61 nonvertebral fractures 61 irbesartan 61 thiazide 61 antihypertensive medication 61 NSAID therapy 61 plasma uric acid 61 antiemetics 61 abciximab 61 Known hypersensitivity 61 NYHA class 61 INCB# [003] 61 serum potassium levels 61 flutamide 61 Hurthle cell 61 peginterferon alfa 61 pathologic fractures 61 Myocardial infarction 61 intact parathyroid hormone 61 ARIXTRA 61 radioiodine therapy 61 AVANDIA 61 microbleeds 61 thrombolytics 61 cerebral vasospasm 61 adalimumab 61 severe hypoglycaemia 61 IV NSCLC 61 steroid dexamethasone 61 lactase deficiency 61 Hypokalemia 61 DMARD 61 liver histology 61 retransplantation 61 elevated intraocular pressure 61 non metastatic osteosarcoma 61 generalized edema 61 hypoglycemic episodes 61 impaired hepatic 61 pyrexia mucositis sepsis febrile 61 jugular venous 61 serum phosphate levels 61 interstitial pneumonitis 61 chronic pancreatitis 61 basal cell nevus syndrome 61 loop diuretic 61 subclinical 61 APTIVUS ritonavir 61 distant metastases 61 resynchronization therapy 61 acute aortic dissection 61 graft dysfunction 61 hyperprolactinemia 61 IFN beta 61 anemia neutropenia 61 vitreous hemorrhage 61 ischemic complications 61 generalized tonic clonic seizures 61 myoclonic seizures 61 urolithiasis 61 mucosal healing 61 Nesiritide 61 unknown etiology 61 coronary revascularization procedures 61 Severe hypoglycemia 61 aspirin clopidogrel 61 hypercoagulable 61 Fanconi syndrome 61 intracerebral hemorrhage 61 olmesartan 61 HBV infections 61 pamidronate 61 perioperatively 61 Clinically significant 61 symptomatic intracranial 61 hematopoietic cancers 61 SCr 61 carotid artery stenosis 61 transferrin saturation 61 lymph node involvement 61 everolimus eluting stents 61 ADPKD 61 thrombolytic agent 61 bronchogenic carcinoma 61 Pioglitazone 61 enzyme elevations 61 mRCC 61 postoperative delirium 61 coronary stenosis 61 prostate cancer CaP 61 airflow obstruction 60 insulin detemir 60 angiotensin converting enzyme ACE 60 curative resection 60 reflux symptoms 60 Thal Dex 60 hypoperfusion 60 trimethoprim sulfamethoxazole 60 NNRTI resistance 60 anticholinergics 60 moderate hepatic impairment 60 angina chest 60 refractory gout 60 interferon alfa 2b 60 Serious adverse reactions 60 azacitidine 60 reintubation 60 hypercholesterolemic patients 60 mEq L 60 nonalcoholic steatohepatitis NASH 60 chemoradiation therapy 60 INTEGRILIN R 60 pulmonary exacerbation 60 oral hypoglycemic agents 60 cardiac troponin T 60 vasopressor 60 DMARDS 60 abdominal adiposity 60 unmeasured confounders 60 HBeAg seroconversion 60 B7 H3 60 coronary artery disease 60 cardiomyopathies 60 metastatic GIST 60 acute gout flares 60 glargine 60 platelet inhibition 60 monoamine oxidase inhibitors 60 radiochemotherapy 60 allogeneic hematopoietic stem cell 60 macrovascular 60 postural hypotension 60 DAPT 60 EDSS scores 60 hepatic cirrhosis 60 elevated creatinine 60 HER2 overexpression 60 gastrointestinal toxicity 60 serum urate 60 peptide BNP 60 alteplase 60 angioedema 60 diabetic kidney 60 fibrinolytic therapy 60 leucopenia 60 pT3 60 elevated CRP 60 carotid atherosclerosis 60 gout flares 60 Lupus nephritis 60 cytoreductive surgery 60 sinus node dysfunction 60 Renal impairment 60 creatinine levels 60 NAbs 60 peritumoral brain edema 60 hypercalciuria 60 CYP#A# inhibitors 60 fosamprenavir 60 dysglycemia 60 QT interval prolongation 60 preserved systolic 60 potentially hepatotoxic 60 antihypertensive drugs 60 hypertriglyceridemia 60 mitral insufficiency 60 hepatic insufficiency 60 antioxidant supplementation 60 coronary calcification 60 urate lowering therapy 60 ß blockers 60 plasminogen activators 60 NOMID 60 tachyarrhythmias 60 colorectal carcinoma 60 venous thromboembolic events 60 triiodothyronine 60 atherosclerotic disease 60 symptomatic hyponatremia 60 lipid lowering therapy 60 isolated systolic hypertension 60 aminotransferase levels 60 intima media thickness 60 inhaled glucocorticoids 60 T1DM 60 nondiabetics 60 cytogenetic abnormalities 60 ventricular tachycardia VT 60 bacterial prostatitis 60 elevated homocysteine 60 necrotizing pancreatitis 60 Exacerbations 60 glucocorticoid therapy 60 elevated transaminases 60 ximelagatran 60 nadolol 60 febrile neutropenia 60 serum phosphorus 60 hyperplasia BPH 60 antithrombotic therapy 60 anthracycline therapy 60 pulmonary capillary wedge 60 calculi 60 acutely decompensated congestive heart 60 catheter angiography 60 poorer prognosis 60 hemodynamically unstable 60 metformin sulfonylurea 60 Subarachnoid hemorrhage 60 lactate dehydrogenase LDH 60 nonfatal myocardial infarction 60 duodenal ulcer 60 primary generalized tonic 60 myeloproliferative diseases 60 Postoperative complications 60 cystoid macular edema 60 Subgroup analyzes 60 immunosuppressive medications 60 chronic myocardial ischemia 60 chronic thromboembolic pulmonary 60 carotid intima media 60 CIMZIA ™ 60 lipid lowering drugs 60 G6PD deficiency 60 intensive statin therapy 60 thrombocytopenia 60 infective endocarditis 60 ADHF 60 Exacerbation 60 recurrent venous thromboembolism 60 bronchopulmonary dysplasia 60 androgen deficiency 60 FOLFOX4 60 pancreatic adenocarcinoma 60 autoantibody positive 60 Atacand 60 hemodilution 60 mitral stenosis 60 dysuria 60 geographic atrophy 60 haemolysis 60 echocardiographic parameters 60 EDARBI 60 analgesic medications 60 cardiac conduction 60 lymphopenia 60 Prehypertension 60 methylprednisolone 60 Calcium intake 60 intracranial bleeding 60 NIHSS score 60 liver metastasis 60 octreotide 60 verapamil 60 AVELOX 60 amyloid deposition 60 LVEF 60 spontaneous bacterial peritonitis 60 LHRH agonists 60 pyridostigmine 60 Stent thrombosis 60 delayed gastric emptying 60 parathyroidectomy 60 octreotide LAR 60 abnormal uterine bleeding 60 dermatologic reactions 60 REMICADE ® 60 Abrupt discontinuation 60 chlorambucil 60 XIENCE V PROMUS Stent 60 cardiac tamponade 60 milrinone 60 serum ALT 60 serum cortisol 60 adenomatous 60 pulmonary resection 60 riociguat 60 NUCYNTA R 60 breast endometrial 60 metastatic RCC 60 PEGINTRON TM 60 oral corticosteroids 60 myelodysplastic syndrome MDS 60 essential thrombocythemia 60 hypoglycaemic episodes 60 Barrett esophagus BE 60 hyperoxaluria 60 retinopathy 60 Vitamin B# deficiency 60 Lp PLA2 60 paralytic ileus 60 nonfatal myocardial infarction MI 60 acromegalic patients 60 ICD shocks 60 leiomyomas 60 chemoradiotherapy 60 spinal cord compression 60 HPA axis suppression 60 biochemical recurrence 60 Ribavirin causes 60 thyrotropin 60 leukocytosis 60 acute coronary syndromes 60 cholelithiasis 60 LOVENOX R 60 undergoing coronary artery 60 intravitreal injections 60 ocular toxicity 60 thioridazine 60 receiving prophylactic anticoagulation 60 candesartan cilexetil 60 PROCRIT 60 gastric ulcers 60 pneumonectomy 60 anemia hemoglobin 60 adjuvant radiotherapy 60 activated partial thromboplastin 60 peripheral sensory neuropathy 60 UA NSTEMI 60 Myelosuppression 60 metastatic malignant melanoma 60 vasospasm 60 intermittent hemodialysis 60 radiotherapy RT 60 corticosteroid dose 60 neoadjuvant chemotherapy 60 invasive candidiasis 60 thromboprophylaxis 60 fragility fracture 60 metabolic abnormalities 59 pleural effusion 59 EFFEXOR XR 59 thrombophlebitis 59 anticlotting drugs 59 NYHA Class III 59 QTc intervals 59 KETEK 59 prostate carcinogenesis 59 CTAP# Capsules 59 peptic ulcer 59 pCR 59 primary hyperparathyroidism 59 metachronous 59 malignant neoplasms 59 oxygen saturations 59 undergoing CABG 59 idarubicin 59 thrombocytopenic patients 59 VELCADE melphalan 59 atrial arrhythmias 59 danazol 59 thyroid dysfunction 59 sotalol 59 pulmonary hypertension PH 59 anterior uveitis 59 endometrial carcinoma 59 hypertensive patients 59 HES CEL 59 cinacalcet 59 endophthalmitis 59 typical antipsychotics 59 cirrhotic patients 59 EEG abnormalities 59 neurological complications 59 pulmonary embolus 59 TNF blocker therapy 59 imatinib therapy 59 cerebrovascular accidents 59 neutropenia thrombocytopenia 59 adjuvant radiation 59 serum uric acid 59 arterial calcification 59 MGd 59 chronic periodontitis 59 liver scarring 59 atherothrombotic events 59 NMIBC 59 systemic amyloidosis 59 ANCA associated 59 non aspirin NSAIDs 59 levodopa carbidopa 59 cystic lesions 59 DMARD therapy 59 intraventricular hemorrhage 59 indomethacin 59 intravascular hemolysis 59 sustained ventricular tachycardia 59 concomitant antibiotics 59 CP CPPS 59 Angioedema 59 dacarbazine 59 NAGS deficiency 59 renoprotective 59 interferon alfa 59 hematuria 59 bradycardia 59 HbA 1c levels 59 homozygous familial hypercholesterolemia 59 lumbar disk herniation 59 methotrexate therapy 59 hypercholesterolemia 59 antiepileptic medications 59 detrusor overactivity 59 paragangliomas 59 gastric adenocarcinoma 59 mitomycin C 59 pernicious anemia 59 elevated LDL cholesterol 59 colectomy 59 ductal cancer 59 postoperative infections 59 symptomatic hypotension 59 relapsed MM 59 estimated glomerular filtration 59 Hyperglycemia 59 non valvular atrial 59 obstructive coronary 59 vWD 59 fallopian tube cancers 59 eplerenone 59 generalized seizures 59 electrolyte disturbances 59 warfarin sodium 59 4mg/kg 59 adjuvant therapy 59 HBeAg positive patients 59 nodal metastases 59 purpura ITP 59 predisposing factor 59 adrenocortical cancer 59 keloid scarring 59 pioglitazone 59 nonmelanoma skin cancer 59 oral Hycamtin 59 nonoperative treatment 59 LATUDA 59 protein excretion 59 ecchymosis 59 onset seizures 59 ruboxistaurin 59 angiotensin receptor blockers 59 carotid artery blockage 59 reperfusion therapy 59 salivary flow 59 macular edema secondary 59 antihypertensive agents 59 malperfusion 59 neurologic sequelae 59 aplastic anemia AA 59 metformin accumulation 59 hypertension diabetes mellitus 59 hyperinsulinemia 59 chronic hepatitis cirrhosis 59 recurrent UTI 59 aortic valve stenosis 59 biochemical relapse 59 unresectable tumors 59 Lp PLA 2 59 diabetes mellitus 59 Heavy menstrual bleeding 59 triglyceride concentration 59 ACE inhibitor ramipril 59 cardiovascular morbidity 59 atherothrombosis 59 clomipramine 59 carotid IMT 59 TAXUS Express Stent 59 bronchial hyperresponsiveness 59 #mmHg [001] 59 candidemia 59 preoperative chemotherapy 59 nonfatal stroke 59 poor metabolizers 59 recurrent ischemic 59 Doxil ® 59 inflammatory biomarkers 59 pulmonary toxicity 59 psychiatric comorbidities 59 idraparinux 59 Asymptomatic 59 NAFLD 59 OPCAB 59 valve regurgitation 59 PRADAXA 59 intraoperative complications 59 AGGRASTAT R 59 somatostatin analogs 59 keloid formation 59 de ath 59 haematologic 59 SCIg 59 GH deficiency 59 urticaria hives 59 potent CYP#A# inhibitors 59 diabetic microvascular complications 59 AA Amyloidosis 59 6R BH4 59 variceal bleeding 59 OSAHS 59 laboratory abnormalities 59 cardioprotection 59 chlorthalidone 59 cTnI 59 keloid scarring treatment 59 advanced neoplasia 59 Non Alcoholic Fatty 59 ischemic colitis 59 Oral corticosteroids 59 immunomodulatory therapy 59 serum PTH 59 dacarbazine DTIC 59 pimecrolimus 59 clinically insignificant 59 Toxicities 59 myocardial infarction ventricular fibrillation 59 nevirapine Viramune 59 specific antigen PSA 59 hypertrophic scars 59 lung resection 59 autoimmune thyroid 59 intraventricular 59 serum calcium 59 androgen deprivation therapy 59 sUA 59 gestational hypertension 59 conventional angiography 59 Atypical Hemolytic Uremic Syndrome 59 ECG abnormalities

Back to home page